Live Breaking News & Updates on Mathias Oelke|Page 2

Stay updated with breaking news from Mathias oelke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NexImmune (NEXI) Announces Publication in Frontiers in Medicine Highlighting the Company's AIM Platform to Treat Viral Diseases

NexImmune (NEXI) Announces Publication in Frontiers in Medicine Highlighting the Company's AIM Platform to Treat Viral Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mathias Oelke , Neximmune Inc , Viral Diseases , Chief Scientific Officer , Artificial Immune Modulation ,

Selexis SA and NexImmune Inc.: Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders

Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papilloma virus (HPV) associated tumors, and additional human leukocyte antigens (HLAs) that ....

Maria Pilar Gim , Mathias Oelke , Markw Womack , Mike Beyer , Company Inquiries For Selexis , Neximmune Inc , Life Sciences , Sam Brown Inc , Chief Executive Officer , Neximmune Chief Scientific Officer , Artificial Immune Modulation , Pilar Gim , Marketing Director ,

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United States , Juanc Varela , Robertd Knight , Scott Carmer , Daniel Bednarik , Maung Myo Htut , Lauren Suarez , Mathias Oelke , Vineetha Edavana , Emily Lu , Sojung Kim , American Society Of Hematology , Exchange Commission , Neximmune Inc , Corporate Affairs , Initial Phase , American Society , Annual Meeting , Preliminary Analysis , Refractory Multiple Myeloma , Andrew Kin , Poster Hall Hours , Artificial Immune Modulation , Private Securities Litigation Reform Act , Annual Report ,

NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results

Initial Phase 1/2 data presented at the 63rd American Society of Hematology (ASH) Annual Meeting and ExpositionPhase 1/2 study of NEXI-002 as a monotherapy. ....

United States , Juanc Varela , Robertd Knight , Scott Carmer , Daniel Bednarik , Maung Myo Htut , Lauren Suarez , Mathias Oelke , Vineetha Edavana , Emily Lu , Sojung Kim , American Society Of Hematology , Exchange Commission , Neximmune Inc , Corporate Affairs , Initial Phase , American Society , Annual Meeting , Preliminary Analysis , Refractory Multiple Myeloma , Andrew Kin , Poster Hall Hours , Artificial Immune Modulation , Private Securities Litigation Reform Act , Annual Report , Nasdaq Nexi ,